Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Acquisitions & Divestments: 2017-2019

Historic Change in Acquisitions & Divestments for Fortress Biotech (FBIO) over the last 3 years, with Dec 2019 value amounting to $5.0 million.

  • Fortress Biotech's Change in Acquisitions & Divestments fell 50.00% to $5.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $32.6 million, marking a year-over-year decrease of 54.08%. This contributed to the annual value of $22.6 million for FY2019, which is 68.16% down from last year.
  • Per Fortress Biotech's latest filing, its Change in Acquisitions & Divestments stood at $5.0 million for Q4 2019, which was down 0.87% from $5.0 million recorded in Q2 2019.
  • Fortress Biotech's Change in Acquisitions & Divestments' 5-year high stood at $25.0 million during Q3 2018, with a 5-year trough of $8,000 in Q2 2017.
  • In the last 3 years, Fortress Biotech's Change in Acquisitions & Divestments had a median value of $11.0 million in 2018 and averaged $11.4 million.
  • As far as peak fluctuations go, Fortress Biotech's Change in Acquisitions & Divestments soared by 149,925.00% in 2018, and later tumbled by 57.97% in 2019.
  • Fortress Biotech's Change in Acquisitions & Divestments (Quarterly) stood at $20.1 million in 2017, then slumped by 50.15% to $10.0 million in 2018, then slumped by 50.00% to $5.0 million in 2019.
  • Its Change in Acquisitions & Divestments was $5.0 million in Q4 2019, compared to $5.0 million in Q2 2019 and $12.6 million in Q1 2019.